Citation Impact
Citing Papers
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
2010
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
2009
Slow Internalization of Anti-HER2 Synthetic Affibody Monomer 111 In-DOTA-Z HER2:342-pep2 : Implications for Development of Labeled Tracers
2008
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Herceptin
2007
Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
2012
Parkinson disease
2017 Standout
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
2007
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
Tumor detection using folate receptor-targeted imaging agents
2008
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
2013
Targeting HER2
2010
Antibody therapy of cancer
2012 Standout
Cardiovascular toxicity caused by cancer treatment: strategies for early detection
2009
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
2010 StandoutNobel
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
2010
Non-motor features of Parkinson disease
2017 Standout
Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer
2007
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
2011
Biomarkers for Parkinson’s Disease
2011
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
2008
Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
2007
N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
2019
Personalized Nanomedicine
2012
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Applications of Clinical Dopamine Imaging
2006
Works of S. Jonkman being referenced
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls
2008
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease
2005
Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
2006